Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Ritchie

Showing results (101-110 of 123) with videos related to

Pageof 13
Sort By:
Ebiomedicine|September 19, 2025
Safety and immunogenicity of two Tau-targeting active immunotherapies, ACI-35.030 and JACI-35.054, in participants with early Alzheimer's disease: a phase 1b/2a, multicentre, double-blind, randomised, placebo-controlled studyOlivier Sol, Julien Mermoud, Merja Hallikainen, et al.
Trials|July 28, 2009
DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCTRob Jones, Bart Sheehan, Patrick Phillips, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersGaurav V Bhalerao, Pawel J Markiewicz, David L Thomas, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 14, 2019
Assessment of need and practice for assistive technology and telecare for people with dementia-The ATTILA (Assistive Technology and Telecare to maintain Independent Living At home for people with dementia) trialKirsty Forsyth, Catherine Henderson, Lucy Davis, et al.
Neuroimage. Clinical|November 21, 2025
Amyloid PET predicts atrophy in older adults without dementia: Results from the AMYPAD Prognostic & Natural History studyLeonard Pieperhoff, Luigi Lorenzini, Sophie Mastenbroek, et al.
The Journal of Prevention of Alzheimer'S Disease|April 25, 2026
Health-economic challenges for new Alzheimer's disease treatmentsJinjing Fu, Anders Sköldunger, Angela Bradshaw, et al.
Neuroimage. Clinical|July 15, 2022
The Open-Access European Prevention of Alzheimer's Dementia (EPAD) MRI dataset and processing workflowLuigi Lorenzini, Silvia Ingala, Alle Meije Wink, et al.
Trials|April 5, 2019
Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)Grazia Daniela Femminella, Eleni Frangou, Sharon B Love, et al.
Trials|July 21, 2020
Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)Grazia Daniela Femminella, Eleni Frangou, Sharon B Love, et al.
Nature Communications|August 9, 2022
Integrated methylome and phenome study of the circulating proteome reveals markers pertinent to brain healthDanni A Gadd, Robert F Hillary, Daniel L McCartney, et al.
Pageof 13

Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
Ebiomedicine|September 19, 2025
Safety and immunogenicity of two Tau-targeting active immunotherapies, ACI-35.030 and JACI-35.054, in participants with early Alzheimer's disease: a phase 1b/2a, multicentre, double-blind, randomised, placebo-controlled studyOlivier Sol, Julien Mermoud, Merja Hallikainen, et al.
Trials|July 28, 2009
DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCTRob Jones, Bart Sheehan, Patrick Phillips, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersGaurav V Bhalerao, Pawel J Markiewicz, David L Thomas, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 14, 2019
Assessment of need and practice for assistive technology and telecare for people with dementia-The ATTILA (Assistive Technology and Telecare to maintain Independent Living At home for people with dementia) trialKirsty Forsyth, Catherine Henderson, Lucy Davis, et al.
Neuroimage. Clinical|November 21, 2025
Amyloid PET predicts atrophy in older adults without dementia: Results from the AMYPAD Prognostic & Natural History studyLeonard Pieperhoff, Luigi Lorenzini, Sophie Mastenbroek, et al.
The Journal of Prevention of Alzheimer'S Disease|April 25, 2026
Health-economic challenges for new Alzheimer's disease treatmentsJinjing Fu, Anders Sköldunger, Angela Bradshaw, et al.
Neuroimage. Clinical|July 15, 2022
The Open-Access European Prevention of Alzheimer's Dementia (EPAD) MRI dataset and processing workflowLuigi Lorenzini, Silvia Ingala, Alle Meije Wink, et al.
Trials|April 5, 2019
Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)Grazia Daniela Femminella, Eleni Frangou, Sharon B Love, et al.
Trials|July 21, 2020
Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)Grazia Daniela Femminella, Eleni Frangou, Sharon B Love, et al.
Nature Communications|August 9, 2022
Integrated methylome and phenome study of the circulating proteome reveals markers pertinent to brain healthDanni A Gadd, Robert F Hillary, Daniel L McCartney, et al.
Pageof 13